Why is Fujian Aonong Biological Technology Group, Inc. Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -8.20% and Operating profit at -178.32% over the last 5 years
- The company is Net-Debt Free
2
The company has declared negative results for the last 3 consecutive quarters
- PRE-TAX PROFIT(Q) At CNY -221.27 MM has Fallen at -640.99%
- NET PROFIT(Q) At CNY -173.31 MM has Fallen at -437.35%
- DEBTORS TURNOVER RATIO(HY) Lowest at 5.93 times
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -44.61%, its profits have fallen by -121.9%
4
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 3.23% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -44.61% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Fujian Aonong Biological Technology Group, Inc. Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Fujian Aonong Biological Technology Group, Inc. Ltd.
-43.89%
-0.60
43.61%
China Shanghai Composite
0.9%
0.22
14.72%
Quality key factors
Factor
Value
Sales Growth (5y)
-8.20%
EBIT Growth (5y)
-178.32%
EBIT to Interest (avg)
-3.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
2.00
Tax Ratio
11.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
11.72%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.32
EV to EBIT
-24.47
EV to EBITDA
2843.31
EV to Capital Employed
1.84
EV to Sales
1.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.52%
ROE (Latest)
-4.84%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-20What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY -221.27 MM has Fallen at -640.99%
NET PROFIT(Q)
At CNY -173.31 MM has Fallen at -437.35%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.93 times
INTEREST(Q)
At CNY 29.59 MM has Grown at 16.85%
RAW MATERIAL COST(Y)
Grown by 143.84% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 74.75 %
Here's what is not working for Fujian Aonong Biological Technology Group, Inc. Ltd.
Pre-Tax Profit
At CNY -221.27 MM has Fallen at -640.99%
over average net sales of the previous four periods of CNY -29.86 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -173.31 MM has Fallen at -437.35%
over average net sales of the previous four periods of CNY -32.25 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 29.59 MM has Grown at 16.85%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debtors Turnover Ratio
Lowest at 5.93 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Debt-Equity Ratio
Highest at 74.75 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 143.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading






